A Study of BBI503 in Adult Patients With Advanced Solid Tumors

NCT01781455 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

311

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer, Advanced Solid Tumors

Interventions

DRUG: BBI503

Sponsor

Sumitomo Pharma America, Inc.